DR. BARUAH HEART CITY

                                                                                                   

                                                                             CITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERINGCITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERING                               &

                 A CITY OF KNOWLEDGE NOT MADE OF BRICKS & MORTAR

Home I C.V. of Dr. dhaniram Baruah I Patient, FDA & Publications I Pre - & Post - TreatmentDoppler Studies Case Report I My Achievements & Significant evidences
 
 Most Popular Categories

Unlimited poweR     of                  GenetiC EngineerinG

Inventor’s mouth.

Consequences of my research.

Introduction.

Mysteries in genetic sciences.

What is coronary artery disease?

Misconceptions in cardio-vascular sciences.

Foundation on which building of Baruah Applied Human.

Revolution in medical sciences rocked by Dr.D.R. Baruah,FRCSGlas.

Unfolding the mysteries in human genetic sciences.

Mysteries in human genetic sciences.

How does the mutation expresses in particular disease form?

Selection of patients for gene analysis

Eradication of heart disease & rarest of the rare diseases- Human genetic studies through sequencing of m-RNA.

Signal Transduction plays a major role during pre-bypass and post-bypass events.

How bypass surgery triggers signal transduction & phenotypically expressed.

Mutation

Selection of genes causing heart & other diseases.

Hypoxia, reactive oxygen species, intracellular calcium & Baruah syndrome.

Re-sequencing of the following genes to identify the mysteries.

First time on this planet– Genovac.

Baruah applied human genetic engineering- a choice of treatment for Cancer.

TGA-A New Method of Treatment of Complex Congenital Heart Disease.

Endocardial Cushion defect.

Genetic Engineering–To cure the rarest of the rare autoimmune.

First time on the Planet–Manifestation of Baruah Syndrome–Moyamoya

The rarest of the rare genetic disorder–Takayasu.

Isolated congenital Right Ventricular Hypertrophy.

---------------------------------------        -----------------------

Applied Human Genetic Engineering - Vol.II

UNFOLDING THE MYSTERIES OF GENETIC SCIENCES IN INCURABLE DISEASES LIKE CORONARY ARTERY DISEASES, CANCER, & RAREST OF THE RARE DISEASES LIKE MOYAMOYA, SLE, TAKAYASU ETC.

CITY OF HUMAN GENOME A INSITUTE OF APPLIED HUMAN GENETIC ENGINEERING

              

TGA-A New Method of Treatment of Complex Congenital Heart Disease-A Revolution in Medical SciencE

 Abstract :-

            A complex congenital heart disease such as transposition of great arteries (TGA) with or without ASD or VSD is not known to be uncommon. The child is borne with TGA with or without ASD or VSD, the common cause of blue babies is known to all clinicians. The child borne with TGA without ASD or VSD and without having patency of ductus aortus has incidence of survival of more than few hours, which is very remote. Atrial septostomy was a standard procedure for long run survival. Infusion of prostaglandin is used to keep the PDA patency as a short term therapy, is also a standard medical practice before taking the patient for corrective surgical procedure. Mustard procedure was a standard one at atrial level which was changed to Senning procedure in different stages of childhood. Switch surgical procedure had started some years ago and it is now a standard surgical procedure of TGA and this should be done within 72 hours after child is borne to obtain good results. However, late complications like stenosis of pulmonary artery and aorta were reported. (TGA-Shilpajyoti Kashyap treated at the age of 9 with Baruah Biological molecules. Her shunt was reversed with asymptomatic with Baruah applied human genetic engineering treatment since 2002.)

          We have used a newly developed isolated plant organic compounds for an eleven year old baby with TGA & VSD where signs and symptoms disappeared and child’s condition has improved clinically and behaving like a normal child. With this discovery, the new era of treatment of congenital anomalies with drugs isolated from medicinal plants has started, which is presented here.

 Introduction:-

           Cyanosis of lips, finger nails, toes, breathlessness, chronic chest infection with cough and cold and fever, retardation of mental and physical growth, low exercise tolerance are the common features of TGA with VSD in later days of childhood. This group of patients do not usually survive beyond their teenage as reported. At this stage, heart-lung transplant has become a standard surgical procedure

 History:-

        Eleven year old girl was brought by parents with following congenital anomaly to our clinic in month of July 2003. She attended two another hospitals where she was sent back home saying that there is no surgical or medical treatment available at this stage. The child had the following signs, symptoms and diagnosis.

Ventricular septal defect (VSD)

TGA

Severe PAH- right to left shunt

Congestion of both liver with impaired liver function

Loss of appetite

Frequent motions and unable to digest the food

Stunted growth

Unable to concentrate her studies

Exercise tolerance was poor and unable to play like a normal child.

Nail beds and lips were completely blue

Clubbing of toes and fingers present

Breathlessness on minimal exertion

Hemoglobin was 18mg%

Colour echocardiography studies reveals VSD, severe PAH- VSD-8mm in size with right to left shunt

          Her parents were agreed to go for heart-lung transplant using pig as a donor. However, as a first step, we have treated her with Baruah biological molecules and treatment was started from July 5th, 2003.

 Results:-

          Three days later, her chest infection and congestion began to disappear and breathlessness was reduced . Blueness of lips, toes and finger nails began to disappear and became pink.  Six days later, she regained her appetite and food intake was increased. We continued the same treatment and on 29th July, post-treatment echo with colour Doppler echocardiography was done.

     The following findings were observed:-

                VSD was measured to be 8mm in size and right to left shunt was changed to left to right with normal ventricular function.

                 No pulmonary hypertension, which was reported earlier.

                 Hemoglobin was reduced by 3mg%

                 She could climb up the hill, she could ride bicycle without exertion. Chest infection was disappeared. Heart size reduced by 1cm. Lung fields were clear. She puts on weight by 2.5 Kgs in 60 days. Clubbing of toes and finger nails were completely disappeared. Hemoglobin was reduced further to 12mg%. Echocardiography studies with colour Doppler in 60 days therapy, reveals that there is no PAH. VSD remains with same diameter. Left to right shunt continues. She has gone back to her school with unrestricted activities. She is continuing the treatment with plant organic compounds and she is surviving without heart-lung transplant.

 Discussion:

                    Our organic compounds from medicinal plants have reduced the higher pressure of morphological right ventricle which is functional left ventricle allowing shunt to reverse where ratio of deoxygenated and oxygenated blood was changed resulting disappearance of cyanosis, improvement of liver function and exercise tolerance. Patients with complex congenital heart disease such as TGA with VSD do not have incidence of long term survival. They have a continuous problems like chest infection, mental retardation, stunted growth, not doing well in the school, breathlessness, and not gaining weight. Heart –lung transplant is the only surgical procedure can be undertaken for these patients with low incidence of survival. High Pulmonary pressure is the major problem. Reduction of PA pressure with reversal of shunt are not known till today treated with conventional therapy such as diuretics, digitalis. This is probably for the first time treated successfully with isolated plant organic compounds. However, long-term results are yet to be seen with this therapy.

Copyright© DR Dhani Ram Baruah  Heart City2007 Best view in 1024 by 768 pixels